Evolution of Alzheimer’s disease related cortical lesions

  • H. Braak
  • E. Braak
  • J. Bohl
  • H. Bratzke
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 54)


Alzheimer’s disease is an immutably progressing dementing disorder. Its major pathologic hallmark is the gradual development of neurofibrillary changes in a few susceptible nerve cell types. The cortical changes do not occur inevitably with advancing age. Once the disease has begun, spontaneous recovery or remissions are not observed. The initial changes develop in poorly myelinated areas of the temporal lobe. The destructive process then follows a predictable pattern as it extends into other cortical areas. Advanced age is not a prerequisite for the evolution of the lesions. Alzheimer’s disease is thus an age-related, but not an age-dependent disease. The spread of the neurofibrillary changes resembles the process of cortical myelination, however in reverse order.

The human cerebral cortex consists of a small allocortex and an extensive neocortex. The allocortex is located chiefly in the anteromedial portions of the temporal lobe and includes the hippocampal formation and the entorhinal region. The subcortical amygdala is closely related. The parietal, occipital, and temporal neocortices are each comprised of a primary core field, a secondary belt region, and related association areas. Sensory data proceeds through the core and belt fields to the respective association areas, and is then conveyed to the frontal association cortex (prefrontal cortex). Tracts generated in this highest organisational level of the human brain guide the data through the frontal belt (premotor areas) to the primary motor area. The striatal loop and the cerebellar loop provide the major routes for this transport. Part of the stream of data from the sensory association areas branches off and converges upon the entorhinal region and the amygdala (afferent leg of the limbic loop). The information is processed in the entorhinal region, amygdala, and hippocampal formation, and projections from all these areas contribute to the efferent leg of the limbic loop, which heads toward the prefrontal cortex (Fig. 1). All components of the limbic loop play a significant role in the maintenance of memory functions. Precisely these areas are susceptible to early and grave pathologic changes in Alzheimer’s disease (AD) (Kemper, 1978).


Neurofibrillary Tangle Association Area Core Field Cortical Destruction Neuropil Thread 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW (1991) The topographical and neuroanatomicai distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cerebral Cortex 1:103–116PubMedCrossRefGoogle Scholar
  2. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Wisniewski HM (1989) Accumulation of abnormally phosphory–lated τ precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477: 90–99PubMedCrossRefGoogle Scholar
  3. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554–567PubMedCrossRefGoogle Scholar
  4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239–259PubMedCrossRefGoogle Scholar
  5. Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 585–613Google Scholar
  6. Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92: 197–201PubMedCrossRefGoogle Scholar
  7. Braak H, Braak E (1997) Aspects of cortical destruction in Alzheimer’s disease. In: Hyman BT, Duyckaerts, Christen Y (eds) Connections, cognition and Alzheimer’s disease. Springer, Berlin Heidelberg New York Tokyo, pp 1–16CrossRefGoogle Scholar
  8. Braak H, Braak E, Yilmazer D, Schultz C, DeVos RAI, Jansen ENH (1995) Nigral and extranigral pathology in Parkinson’s disease. J Neural Transm [Suppl] 46: 15–31Google Scholar
  9. Duyckaerts C, Delaère P, He Y, Camilleri S, Braak H, Piette F, Hauw JJ (1995) The relative merits of tau- and amyloid markers in the neuropathology of Alzheimer’s disease. In: Bergener M, Finkel SI (eds) Treating Alzheimer’s and other dementias. Springer, New York, pp 81–89Google Scholar
  10. Flechsig P (1920) Anatomie des menschlichen Gehirns und Rückenmarks auf myelogenetischer Grundlage. Thieme, LeipzigGoogle Scholar
  11. Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci 16: 460–465PubMedCrossRefGoogle Scholar
  12. Hyman BT, Gomez-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific diasease, not a global brain disease. Neurobiol Aging 15: 353–354PubMedCrossRefGoogle Scholar
  13. Hyman BT, van Hoesen GW, Damasio AR (1990) Memory-related neural systems in Alzheimer’s disease: an anatomic study. Neurology 40: 1721–1730PubMedCrossRefGoogle Scholar
  14. Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I (1994) Mechanism of neurofibrillary degeneration in Alzheimer’s disease. Mol Neurobiol 9: 119–123PubMedCrossRefGoogle Scholar
  15. Kapfhammer JP, Schwab ME (1994) Inverse patterns of myelination and GAP-43 expression in the adult CNS: neurite growth inhibitors as regulators of neuronal plasticity. J Comp Neurol 340: 194–206PubMedCrossRefGoogle Scholar
  16. Kemper TL (1978) Senile dementia: a focal disease in the temporal lobe. In: Nandy E (ed) Senile dementia: a biomedical approach. Elsevier, Amsterdam, pp 105–113Google Scholar
  17. McGeer PL, McGeer EG, Akiyama H, Itagaki S, Harrop R, Peppard R (1990) Neuronal degeneration and memory loss in Alzheimer’s disease and aging. Exp Brain Res [Suppl]21: 411–426 Ohm TG, Müller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer’s disease-related neurofibrillary changes. Neuroscience 64: 209–217Google Scholar
  18. Ohm TG, Müller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer’s disease-related neurofibrillary changes. Neuroscience 64: 209–217PubMedCrossRefGoogle Scholar
  19. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging 12: 295–312PubMedCrossRefGoogle Scholar
  20. Reisberg B, Pattschull-Furlan A, Franssen E, Sclan SG, Kluger A, Dingcong L, Ferris SH (1992) Dementia of the Alzheimer type recapitulates ontogeny inversely on specific ordinal and temporal parameters. In: Kostovic I, Knezevic S, Wisniewski HM, Spillich GJ (eds) Neurodevelopment, aging and cognition. Birkhäuser, Boston, pp 345–369CrossRefGoogle Scholar
  21. Schwab ME (1990) Myelin-associated inhibitors of neurite growth and regeneration in the CNS. Trends Neurosci 13: 452–456PubMedCrossRefGoogle Scholar
  22. Trojanowski JQ, Shin RW, Schmidt ML, Lee VMY (1995) Relationship between plaques, tangles, and dystrophic processes in Alzheimer’s disease. Neurobiol Aging 16: 335–340PubMedCrossRefGoogle Scholar
  23. van Hoesen GW, Hyman BT, Damasio AR (1991) Entorhinal cortex pathology in Alzheimer’s disease. Hippocampus 1: 1–8PubMedCrossRefGoogle Scholar
  24. Yakovlev PI, Lecours AR (1967) The myelogenetic cycles of regional maturation of the brain. In: Minkowksi A (ed) Regional development of the brain in early life. Blackwell, Oxford, pp 3–70Google Scholar

Copyright information

© Springer-Verlag/Wien 1998

Authors and Affiliations

  • H. Braak
    • 1
  • E. Braak
    • 1
  • J. Bohl
    • 2
  • H. Bratzke
    • 3
  1. 1.Department of AnatomyJ.W. Goethe UniversityFrankfurtFederal Republic of Germany
  2. 2.Department of NeuropathologyJ. Gutenberg UniversityMainzFederal Republic of Germany
  3. 3.Department of Forensic MedicineJ.W. Goethe UniversityFrankfurtFederal Republic of Germany

Personalised recommendations